465 related articles for article (PubMed ID: 18081648)
21. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
[TBL] [Abstract][Full Text] [Related]
22. Appropriateness of colonoscopy in Europe (EPAGE II). Chronic diarrhea and known inflammatory bowel disease.
Schusselé Filliettaz S; Juillerat P; Burnand B; Arditi C; Windsor A; Beglinger C; Dubois RW; Peytremann-Bridevaux I; Pittet V; Gonvers JJ; Froehlich F; Vader JP;
Endoscopy; 2009 Mar; 41(3):218-26. PubMed ID: 19280533
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer in idiopathic inflammatory bowel disease.
Harpaz N; Talbot IC
Semin Diagn Pathol; 1996 Nov; 13(4):339-57. PubMed ID: 8946611
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
25. Pathology of dysplasia and cancer in inflammatory bowel disease.
Mescoli C; Frego M; Rugge M
Ann Ital Chir; 2011; 82(1):11-8. PubMed ID: 21657150
[TBL] [Abstract][Full Text] [Related]
26. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
[TBL] [Abstract][Full Text] [Related]
27. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
Imam MH; Thackeray EW; Lindor KD
Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
[TBL] [Abstract][Full Text] [Related]
28. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
29. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
30. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
[TBL] [Abstract][Full Text] [Related]
31. Reduction of colorectal cancer risk in patients with Crohn's disease.
Lichtenstein GR
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
[TBL] [Abstract][Full Text] [Related]
32. Malignant transformation in inflammatory bowel disease - surveillance guide.
Stallmach A; Bielecki C; Schmidt C
Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
[TBL] [Abstract][Full Text] [Related]
33. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
34. [Colorectal cancer in inflammatory bowel disease].
Henriksen M; Moum B
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
[TBL] [Abstract][Full Text] [Related]
35. Dysplasia in inflammatory bowel disease.
Greenson JK
Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
[TBL] [Abstract][Full Text] [Related]
36. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions.
Konda A; Duffy MC
Gastroenterol Clin North Am; 2008 Mar; 37(1):191-213, viii. PubMed ID: 18313546
[TBL] [Abstract][Full Text] [Related]
37. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
Risques RA; Rabinovitch PS; Brentnall TA
Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
[TBL] [Abstract][Full Text] [Related]
38. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
39. IBD-related carcinoma and lymphoma.
Claessen MM; Siersema PD; Vleggaar FP
Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]